Vaccines that treat cancer could be accessible to patients as early as the next decade, say the BioNTech developers.
While scientists are tentative about using the term "cure", the cancer vaccine in progress may have the potential to significantly treat and fight cancer cells.
Professor Ugur Sahin and Ozlem Tureci (Above), have found new "breakthroughs" in treating cancer cells, which they attribute to their earlier work on the COVID vaccine.
The duo previously worked together to pioneer cancer immunotherapies tailored to individual patients, having co-founded BioNTech together in Mainz, Germany, in 2008.
The husband-and-wife team, who successfully developed theche Pfizer vaccine, have said their progress during the pandemic on the use of mRNA technology "gives back to our cancer work". READ MORE...
No comments:
Post a Comment